The prostate stem cell is a target of vitamin D chemoprevention
The prostate stem cell is a target of vitamin D chemoprevention
批准号:
8469833
负责人:
Scott D Cramer
金额:
$28.46万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-06 至 2015-05-31
关键词:
AKT1 geneAdultAllelesAndrogen ReceptorAnimalsApoptosisBenignBicalutamideBiological AssayBromodeoxyuridineCarcinomaCell CycleCell Cycle ArrestCell Cycle ProgressionCellsChemopreventionCholecalciferolCleaved cellDataDietDiseaseEpithelial CellsExhibitsGene ExpressionGenetic ModelsGrowthHealthHistopathologyHumanIL1R1 geneImmunohistochemistryIn VitroInterleukin-1Interleukin-1 alphaIntraepithelial NeoplasiaMalignant neoplasm of prostateMediatingModelingMusNuclearOncogenesPathway interactionsPreventionProcessProliferation MarkerProstateProstate carcinomaProstaticProstatic Intraepithelial NeoplasiasProstatic NeoplasmsProtein IsoformsProto-Oncogene Proteins c-aktRNAReceptor SignalingRegulationRelative (related person)ReporterRoleSignal PathwaySignal TransductionStem cellsSupplementationTestingTissue RecombinationTissuesVitamin DVitamin D Response ElementVitamin D2Vitamin D3 Receptorcancer riskcaspase-3cell growthchromatin immunoprecipitationdeletion analysisextracellularfeedingin vivomouse modelnoveloncoprotein p21progenitorpromoterprostate cancer preventionprostate carcinogenesispublic health relevancereceptorreceptor expressionresponsesenescencesmall hairpin RNAtumor progressiontumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Circulating vitamin D levels are inversely associated with prostate cancer risk and supplementation with vitamin D for prostate cancer prevention has been proposed. We recently developed a mouse model of adult prostate progenitor/stem cells (PrP/SC). The adult tissue specific stem cell may be an important target for chemoprevention. We have interrogated the effects of the active metabolite of vitamin D, 1a,25-dihydroxyvitamin D3 [1,25(OH)2D3], on the PrP/SC. 1,25(OH)2D3 blocks proliferation, induces cell cycle arrest, and increases expression of cyclin-dependent kinase inhibitors p21 and p27. Our data suggest that 1,25(OH)2D3 promotes differentiation of the PrP/SC. Consistent with prodifferentiation we observe increased androgen receptor (AR) expression in 1,25(OH)2D3-treated PrP/SC. To identify novel targets of vitamin D receptor transcriptional activity and to assess global gene expression changes we probed gene expression arrays with RNA from 1,25(OH)2D3-treated PrP/SC. We identified a signaling pathway that is both necessary and sufficient for 1,25(OH)2D3 antiproliferative actions on the PrP/SC and is required for induction of AR. Preliminary data also demonstrate a moderate cell cycle block and a more profound induction of senescence, which is dependent on this pathway. This project will interrogate the role of this pathway in vitamin D signaling in the prostate stem cell in more detail. We will evaluate the mechanism of regulation by vitamin D and how this pathway intersects with AR signaling, we will determine the signaling pathway leading to senescence in response to vitamin D both in vitro and in vivo, and we will test the ability of vitamin D to block prostate tumor progression in a genetic model of prostate cancer that exhibits progression through prostatic intraepithelial neoplasia in a p27-dependent manner. Overall these studies will impact our understanding of the effects of vitamin D signaling on prostate stem cell growth arrest, differentiation and senescence and the functional roles of vitamin D in the prevention of prostate tumor progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10657393
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10276486
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10439892
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:10332080
-
项目类别:
-
资助金额:$25.18万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Autophagy regulation of prostate tumor development
-
批准号:9096644
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:9404559
-
项目类别:
-
资助金额:$0.54万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:9312767
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:10670055
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
-
批准号:9265055
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and TAK1 Synthetic Lethality in Prostate Cancer
-
批准号:8873686
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
-
批准号:9090060
-
项目类别:
-
资助金额:$38.87万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and TAK1 Synthetic Lethality in Prostate Cancer
-
批准号:9047256
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
Isolation of Tumor Initiating Cells (TICs) using Contactless Dielectrophoresis
-
批准号:8547799
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2012
-
负责人:Scott D Cramer
-
依托单位:
Isolation of Tumor Initiating Cells (TICs) using Contactless Dielectrophoresis
-
批准号:8431874
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2012
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8676711
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8326107
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8105199
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:8053797
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:7828004
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:8316493
-
项目类别:
-
资助金额:$21.24万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
海外基金